Healthcare stocks lift European markets higher; Novo Nordisk jumps 3.4%

VTB Bank, Russia’s second-biggest lender, reported a 27.6% year-on-year rise in annual net profit on Tuesday, with the figure for 2024 coming in at 551.4 billion rubles ($6.4 billion).

Chief Financial Officer Dmitry Pianov said in a news release that it marked a record result for the bank, with profitability bolstered by a growing loan portfolio and a record expansion in retail customers. However, the company noted that tighter monetary policy — the Bank of Russia has held its key interest rate at 21% since October — led to a deceleration in its lending growth as the year progressed.

VTB’s 2024 result marked a continued financial recovery for the lender, topping the record profit it reported a year earlier. In 2022, VTB reported a 667.5 billion ruble loss after the lender was hit by international sanctions imposed in response to Russia’s full-scale invasion of Ukraine.

— Chloe Taylor

In a report out Tuesday, Munich’s Ifo Institute said that German businesses became slightly less pessimistic about foreign sales prospects in February, with the thinktank’s Export Expectations indicator a rise to -5 points from -7.1 points a month earlier.

Despite the slight uptick, Ifo noted that the figure has been in negative territory for almost two years, with “only a few sectors” — including furniture manufacturers, beverage makers and the autos sector — projecting international sales will pick up.

German machinery manufacturers and the country’s chemicals sector were expecting a slight decline in international sales, Ifo’s data showed.

The data was derived from survey responses from around 2,100 firms.

— Chloe Taylor

Ryanair CEO Michael O’Leary on Tuesday said that the budget airline expects fares to be 4% to 6% higher this summer than in the same season of 2024, in comments cited by news agency Reuters.

Dublin-listed shares of the company were trading flat at 10:14 a.m. London time.

— Chloe Taylor

Smith & Nephew shares jumped 8% at the open after the British medical technology company reported its full-year results.

Annual revenue rose to $5.8 billion in 2024, a 4.7% rise from the $5.5 billion reported in 2023, the company said in a Tuesday statement. Meanwhile, trading profit increased 8.2% to just over $1 billion in 2024, up from $970 million in 2023.

The company noted an improvement in demand for its U.S. hip implant and knee implant products which helped offset a decline in China. It’s expecting underlying revenue growth of around 5% in 2025, compared to growth of 4.8% in 2024.

“We have been driving a three-year turnaround, we’re two years into that turnaround, and we’ve been very pleased with the results. So far, Q4 was strong with a strong finish to the year and we delivered above five percent growth, which is higher than our historical average of about two to three percent growth,” Smith & Nephew CEO Deepak Nath told CNBC in an interview on Tuesday.

“We’re looking forward to in 2025, the accumulated benefits, and all the operational improvements we made in 2024 to deliver exceptional returns financially,” Nath added.

— Sawdah Bhaimiya

German healthcare company Fresenius Medical Care said Tuesday that it has installed its first-ever “tariff taskforce” to manage uncertainty surrounding U.S. President Donald Trump’s proposed import charges.

CEO Helen Giza told CNBC that her business was somewhat insulated from possible trade levies, with some U.S.-based manufacturing. However, she noted that charges on EU imports could hit items such as its dialysis machines and consumable products.

“Clearly we’re looking at what happens to the tariffs in Europe and what also happens to tariffs [on] medical equipment,” she said.

“The escalation and speed of this with the executive orders is something we assembled pretty quickly,” Giza added. She noted that the taskforce had an expanded remit to the company’s regular trade team and was trying to understand the implications of levies and “what the potential scenarios could be.”

— Karen Gilchrist

Germany’s economy contracted 0.2% quarter-on-quarter in the final three months of 2024, the country’s Federal Statistical Office said on Tuesday, confirming a preliminary reading out at the end of January.

The fourth-quarter performance followed quarterly growth of 0.1% over the July-September stretch.

Officials cited significant export declines and an ongoing slump in manufacturing output among the headwinds facing the German economy at the end of last year.  

— Chloe Taylor

Unilever CEO Hein Schumacher is stepping down after less than two years in the job, the company said Tuesday, with current CFO Fernando Fernandez set to take his place leading the company.

Schumacher — who took the reins in July 2023 and was tasked with leading the overhaul of the consumer goods giant — will stand down as CEO and board director in March and will leave the company on May 31. His departure is taking place by mutual agreement, the consumer goods firm said.

Fernandez’ new role will take effect March 1.

Unilever said there was no change to its 2025 outlook or the company’s medium-term guidance following this announcement.

“On behalf of the Board, I would like to thank Hein for resetting Unilever’s strategy, for the focus and discipline he has brought to the company and for the solid financial progress delivered during 2024,” Unilever Chairman Ian Meakins said in a statement.

“While the Board is pleased with Unilever’s performance in 2024, there is much further to go to deliver best-in-class results. Having worked with Fernando closely over the last 14months, the Board is very confident in his ability to lead a high performing management team, realize the benefits of the GAP [Growth Action Plan] with urgency, and deliver the shareholder value that the company’s potential demands,” Meakins added.

Srinivas Phatak, Unilever’s current deputy CFO and group controller, will take over as interim CFO. An internal and external search now being initiated to permanently fill the role, the company added.

— Karen Gilchrist

Frankfurt’s DAX index gained 0.6% Monday, outpacing a flat U.K. FTSE 100 and 0.78% loss for France’s CAC 40, while the euro nudged higher against the U.S. dollar and British pound and German borrowing costs were little-changed.

Germany’s election delivered a victory for the conservative alliance of the Christian Democratic Union (CDU) and Christian Social Union (CSU). That has set up CDU-CSU candidate Friedrich Merz — a center-right, pro-business politician who serves on the boards of EY Germany and the Deutsche Börse — as near-certain to take over as the next chancellor.

Some uncertainty remains however, with a period of coalition talks ahead and a future in which support of smaller parties will be needed to enact promised policies including reform of Germany’s contentious “debt brake” rule.

Read the full story here.

— Jenni Reid

European markets are expected to open in mixed territory Tuesday.

The U.K.’s FTSE 100 index is expected to open unchanged at 8,637, Germany’s DAX down 29 points at 22,381, France’s CAC 2 points lower at 8,084 and Italy’s FTSE MIB 27 points higher at 38,542, according to data from IG.

Earnings come from Fresenius Medical Care, Smith & Nephew, Heidelberg materials and Alcon. On the data front, final fourth-quarter German gross domestic product data will be released.

— Holly Ellyatt